Definitive Contract 75A50123C00065
Award Date
9/30/23
Potential Completion Date
8/2/27
Potential Value
$339M
Awardee
Castlevax Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10014, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a Cost Sharing Definitive Contract to Vaccitech (UK) LIMITED, a For Profit Organization, for the advanced research and development of vaccine candidates to address Chemical, Biological, Radiological, Nuclear (CBRN), pandemic influenza, and emerging infectious disease threats to the U.S. civilian population. The $9,299,269.00 contract, awarded on February 12, 2019, supports...
This $100,000,000.00 definitive, firm fixed-price contract was awarded by the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The contract is for the design and administration of incentive prize competitions to accelerate the development and commercialization of new medical countermeasure technologies, with an initial focus on...
This definitive contract award of $749,000 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response is for Vaxess Technologies Inc. to deliver its MIMIX-COVID pre-fusion spike protein vaccine patch at scale. The prime contractor will manufacture up to 100 million shelf-stable, self-applied single-dose vaccine patches in response to Special Instructions 019 under the Easy Broad Agency Announcement BAA-20-100-SOL-0002. This solicitation...
This federal contract award, valued at $228,598,975.00, was issued by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Janssen Research & Development, LLC. The award is not associated with a set-aside designation. The contract is for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats, in support of ASPR's Public Health...
This is a $8,650,565,549.53 Firm Fixed Price definitive contract awarded to Pfizer Inc. by the Office of the Assistant Secretary for Preparedness and Response (ASPR) for the provision of COVID-19 vaccines. The contract has an ultimate completion date of May 29, 2024 and was awarded on October 1, 2022 without any set-aside designation. Pfizer, a global pharmaceutical manufacturer, is the prime contractor for this award. The contract supports the government's COVID-19 vaccine initiatives and is...
This definitive contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Moderna US, Inc. for COVID-19 vaccinations in support of the 2022 Fall Vaccine Campaign. The $7.8 billion firm fixed price contract is a transfer from the original awarding agency, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, and represents continuation of vaccine production...
This is a $433,190,532.00 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Gritstone Bio, Inc. for the development of a next-generation COVID-19 vaccine capable of generating durable and broad neutralizing antibodies against variants of concern as well as T-cell responses against conserved viral targets. The contract is not set aside and was awarded under a Broad Agency Announcement (BAA) from BARDA, the Biomedical Advanced...
This is a $1,754,345,480.45 definitive cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Moderna, Inc. for the development of an mRNA vaccine to licensure for the prevention of COVID-19. The contract includes pre-award costs, development of the mRNA vaccine to Biologics License Application (BLA), and domestic manufacturing scale-out. This award does not have a set-aside designation. Moderna, a for-profit pharmaceutical...
This is a federal contract award to Protein Sciences Corp, a for-profit vaccine manufacturer, by the U.S. Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $2,146,389.00 firm fixed-price contract is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The purpose of the award is for Protein Sciences to manufacture 1 bulk lot of an H7 vaccine. No set-aside designation was...
This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...